The Future of 5G at IWCE 2019

 

An innovation cannot truly be labeled as such if end-users are unable to use it. Education around new products is critical to the advancement of industry and technology and the 5G movement currently stands in flux as people try to absorb what it is capable of.

At IWCE 2019, MarketScale asked experts and industry insiders what concerned them about the public perception of 5G and what must be done before and during the quickly-approaching rollout of this new era for wireless connectivity.

“There needs to be more education of the technologies that are being worked on,” Teresa Maher, President of ETA International, said.

Not only are students not receiving the necessary training to utilize 5G and other connected technology, but the current workforce is not being educated enough while on the job, some at IWCE claimed.

“The industry lacks a certified registration program for installers, designers and people who do annual maintenance and testing on systems,” Alan Perdue, executive director of the Safer Buildings Coalition, said.

5G providers and signal carriers will have to find a way to educate more people, including business owners and executives, of the benefits of the service. That is why conferences like IWCE 2019 are so important to the near future of connectivity.

According to the Harvard Business Review, there is still significant doubt and skepticism among business leaders of the impact of 5G. Without the embrace from this community, 5G may not get the credit it deserves as a revolutionary upgrade in speed and connectivity.

For the latest news, videos, and podcasts in the IoT Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @IOTMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More